Moderna, Google DeepMind, Biocon on AI in Science
Noubar Afeyan, Co-Founder & Chairman, Moderna and Founder & CEO, Flagship Pioneering; Lila Ibrahim, Chief AI Readiness Officer, Google DeepMind; and Kiran Mazumdar-Shaw, Founder & Executive Chairperson, Biocon discuss how AI is reshaping scientific discovery with Bloomberg's Francine Lacqua at the…
This article discusses how AI is transforming scientific discovery, featuring insights from Noubar Afeyan of Moderna and Flagship Pioneering, Lila Ibrahim of Google DeepMind, and Kiran Mazumdar-Shaw of Biocon, as they speak with Bloomberg's Francine Lacqua at the 2026 Bloomberg New Economy Forum in New Delhi.
What happened
Noubar Afeyan, Lila Ibrahim, and Kiran Mazumdar-Shaw discussed the impact of AI on scientific discovery during a panel at the 2026 Bloomberg New Economy Forum in New Delhi, hosted by Bloomberg's Francine Lacqua.
Why it matters
The discussion highlights the growing integration of AI in scientific research, which can accelerate innovation and improve outcomes in fields like biotechnology and pharmaceuticals.
- AI is playing a transformative role in scientific research.
- Industry leaders are actively exploring AI applications in biotechnology and pharmaceuticals.
- Collaboration between AI experts and scientific researchers is driving innovation.
The bigger picture
The integration of AI in scientific discovery has the potential to significantly enhance research efficiency and lead to breakthroughs in various scientific domains.
The article underscores the growing influence of AI in scientific discovery, with insights from leading experts in biotechnology, AI, and pharmaceuticals.
Technical details
- AI is being used to analyze complex data and identify patterns in scientific research.
- AI tools are being developed to support drug discovery and biotechnology applications.
FAQ
What is the main topic of the article?
The article discusses how AI is reshaping scientific discovery, with insights from industry leaders at the 2026 Bloomberg New Economy Forum.
Who are the key participants in the discussion?
Noubar Afeyan of Moderna and Flagship Pioneering, Lila Ibrahim of Google DeepMind, and Kiran Mazumdar-Shaw of Biocon.
Where did the discussion take place?
The discussion took place at the 2026 Bloomberg New Economy Forum in New Delhi.
This summary and analysis were generated with AI from the original article and may contain errors. Read the original for the full story.
Read the full story
Originally published by Bloomberg Technology on Oct 13, 2026.
Comments
Sign in to join the discussion.